Cargando…

Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection

The dynamics of immune responses in asymptomatic SARS-CoV-2–infected subjects remain to be fully characterized. The work presented in this issue of JEM by Le Bert et al. (2021. J. Exp. Med. https://doi.org/10.1084/jem.20202617) sheds some light on these issues and ultimately provides some degree of...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kedl, Ross M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Insights
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056771/ https://www.ncbi.nlm.nih.gov/pubmed/33861846 http://dx.doi.org/10.1084/jem.20210359

Ejemplares similares

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

Lasting memories of SARS-CoV-2 infection
por: Poon, Maya M.L., et al.
Publicado: (2021)

Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection
por: Llach, Cristian-Daniel, et al.
Publicado: (2021)

SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies
por: Que, Haiying, et al.
Publicado: (2022)

The early interferon catches the SARS-CoV-2
por: Decker, Thomas
Publicado: (2021)

On the origin of SARS-CoV-2—The blind watchmaker argument
por: Wu, Chung-I, et al.
Publicado: (2021)

SARS-CoV-2 shows a much earlier divergence in the world than in the Chinese mainland
por: Cheng, Chaoyuan, et al.
Publicado: (2023)

The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion
por: Li, Zhengqian, et al.
Publicado: (2020)

Clinical pearls and pitfalls of SARS-CoV-2 serology
por: Lippi, Giuseppe, et al.
Publicado: (2023)

AIDS patient with severe T cell depletion achieved control but not clearance of SARS‐CoV‐2 infection
por: Spinicci, Michele, et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced cerebral venous thrombosis
por: Ciccone, Alfonso
Publicado: (2021)

Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Iron out KRAS-driven cancer
por: Lei, Guang, et al.
Publicado: (2022)

Enabling out-of-body experiences for living organs
por: Ingber, Donald E.
Publicado: (2021)

Some research advances of immune mechanism during infection in China
por: Yang, Wei
Publicado: (2012)

Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems
por: da Silva, Severino Jefferson Ribeiro, et al.
Publicado: (2020)

Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections
por: Orenstein, Robert, et al.
Publicado: (2023)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination
por: Jarisch, Andrea, et al.
Publicado: (2022)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

Breathe—Your immune system is counting on it
por: McCarty, Nael A.
Publicado: (2021)

SARS-CoV-2 tests in occupational settings: what you look for is what you get
por: Ferrari, Luca, et al.
Publicado: (2021)

TB granuloma: CD30 co-stimulation for CD4(+) T cell co-operation
por: Gress, Abigail R., et al.
Publicado: (2023)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

An unconventional view of COVID-19 T cell immunity
por: Koay, Hui-Fern, et al.
Publicado: (2020)

mTEC damage risks immune recovery
por: Takahama, Yousuke
Publicado: (2021)

Immune cells—A curse and a blessing!
por: Mirakaj, Valbona
Publicado: (2021)

How far can droplets spread following an aerosol generating procedure in the dental setting?
por: Papadaki, Sofia
Publicado: (2022)

Immune-mediated vincristine-induced neuropathy: Unlocking therapies
por: Savelieff, Masha G., et al.
Publicado: (2021)

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
por: Garrido, Carolina, et al.
Publicado: (2021)

International Perspectives Concerning Donor Milk Banking During the SARS-CoV-2 (COVID-19) Pandemic
por: Marinelli, Kathleen A.
Publicado: (2020)

New twists in humoral immune regulation by SLAM family receptors
por: Qi, Hai
Publicado: (2021)

Implementing immunization program efficiently, and establishing national database of adverse reactions
por: Gao, George Fu
Publicado: (2014)

Evidence for Aerosol Transfer of SARS-CoV-2–Specific Humoral Immunity
por: Kedl, Ross M., et al.
Publicado: (2023)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
por: Siggins, Matthew K., et al.
Publicado: (2021)

Decision by injection without infection
por: Sasai, Miwa, et al.
Publicado: (2020)

Translational switching from growth to defense – a common role for TOR in plant and mammalian immunity?
por: Zanetti, María Eugenia, et al.
Publicado: (2017)

Top or Middle? Up or Down? Toward a Standard Lexicon for Protein Top-Down and Allied Mass Spectrometry Approaches
por: Lermyte, Frederik, et al.
Publicado: (2019)

Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
por: Field, C. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ad0aqvl4s8jm47jd7pjigeogt9